Kosacz Barbara is COO & General Counsel of Kronos Bio Inc.
Person profile
Roles
Address
Palo Alto, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CERO THERAPEUTICS HOLDINGS, INC.
16 Feb 24
4
Kronos Bio, Inc.
5 Jan 24
4
Athira Pharma, Inc.
22 May 23
4
XOMA Corp
19 May 23
4
Kronos Bio, Inc.
17 Feb 23
4
Kronos Bio, Inc.
27 Jul 22
4
Athira Pharma, Inc.
27 May 22
4
XOMA Corp
20 May 22
4
Kronos Bio, Inc.
17 Feb 22
4
PHOENIX BIOTECH ACQUISITION CORP.
12 Oct 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 24 | CERO Phoenix Biotech Acquisition | Class A Common Stock | Other | Acquire J | No | No | 0 | 5,828 | 0.00 | 5,828 |
4 Jan 24 | KRON Kronos Bio | Common Stock | Sell | Dispose S | No | No | 1.1836 | 10,676 | 12.64 k | 928,966 |
19 May 23 | ATHA Athira Pharma | Stock Option Common Stock | Grant | Acquire A | No | No | 2.89 | 20,900 | 60.40 k | 20,900 |
17 May 23 | XOMA XOMA | Non-Qualified Share Option Common Shares | Grant | Acquire A | No | No | 21.39 | 10,967 | 234.58 k | 10,967 |
15 Feb 23 | KRON Kronos Bio | Common Stock | Grant | Acquire A | No | No | 0 | 138,911 | 0.00 | 939,642 |
15 Feb 23 | KRON Kronos Bio | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.09 | 208,367 | 435.49 k | 208,367 |